Genome-wide comparison between IL-17A- And IL-17F-induced effects in human rheumatoid arthritis synoviocytes

Journal of Immunology

Volumn 182, Issue 5, 2009, Pages 3112-3120

  Zrioual, Saloua ^a   Ecochard, René ^b   Tournadre, Anne ^b   Lenief, Vanina ^a   Cazalis, Marie Angélique ^a   Miossec, Pierre ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b Hospices Civils ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CYTOKINE; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 32; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; NEUTRALIZING ANTIBODY; PROTEIN LPL; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; AUTACOID; IL17A PROTEIN, HUMAN; IL17F PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; OSTEOARTHRITIS; PATHOGENESIS; PLASMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; TH17 CELL; VALIDATION STUDY; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; HUMAN GENOME; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SYNOVIUM;

ARTHRITIS, RHEUMATOID; CELLS, CULTURED; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-17; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOARTHRITIS; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 64849100544     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0801967     Document Type: Article

References (61)

1. Kirkham, B. W., M. N. Lassere, J. P. Edmonds, K. M. Juhasz, P. A. Bird, C. S. Lee, R. Shnier, and I. J. Portek. 2006. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum. 54: 1122-1131.
2. Lubberts, E., M. I. Koenders, B. Oppers-Walgreen, L. van den Bersselaar, C. J. Coenen-de Roo, L. A. Joosten, and W. B. van den Berg. 2004. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 50: 650-659.
3. Nakae, S., A. Nambu, K. Sudo, and Y. Iwakura. 2003. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171: 6173-6177.
4. Kotake, S., N. Udagawa, N. Takahashi, K. Matsuzaki, K. Itoh, S. Ishiyama, S. Saito, K. Inoue, N. Kamatani, M. T. Gillespie, et al. 1999. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103: 1345-1352.
5. Van Bezooijen, R. L., L. Van Der Wee-Pals, S. E. Papapoulos, and C. W. Lowik. 2002. Interleukin 17 synergises with tumour necrosis factor α to induce cartilage destruction in vitro. Ann. Rheum Dis. 61: 870-876.
6. Koshy, P. J., N. Henderson, C. Logan, P. F. Life, T. E. Cawston, and A. D. Rowan. 2002. Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines. Ann. Rheum Dis. 61: 704-713.
7. Parsonage, G., A. Filer, M. Bik, D. Hardie, S. Lax, K. Howlett, L. D. Church, K. Raza, S. H. Wong, E. Trebilcock, et al. 2008. Prolonged, granulocyte-macrophage colony-stimulating factor-dependent, neutrophil survival following rheumatoid synovial fibroblast activation by IL-17 and TNFα. Arthritis Res. Ther. 10: R47.
8. + T helper cells. Cell 126: 1121-1133.
9. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
10. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132.
11. Hymowitz, S. G., E. H. Filvaroff, J. P. Yin, J. Lee, L. Cai, P. Risser, M. Maruoka, W. Mao, J. Foster, R. F. Kelley, et al. 2001. IL-17s adopt a cysteine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J. 20: 5332-5341.
12. Fossiez, F., O. Djossou, P. Chomarat, L. Flores-Romo, S. Ait-Yahia, C. Maat, J. J. Pin, P. Garrone, E. Garcia, S. Saeland, et al. 1996. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183: 2593-2603.
13. Liang, S. C., A. J. Long, F. Bennett, M. J. Whitters, R. Karim, M. Collins, S. J. Goldman, K. Dunussi-Joannopoulos, C. M. Williams, J. F. Wright, and L. A. Fouser. 2007. An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J. Immunol. 179: 7791-7799.
14. Chang, S. H., and C. Dong. 2007. A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses. Cell Res. 17: 435-440.
15. Toy, D., D. Kugler, M. Wolfson, T. Vanden Bos, J. Gurgel, J. Derry, J. Tocker, and J. Peschon. 2006. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J. Immunol. 177: 36-39.
16. Arnett, F. C., S. M. Edworthy, D. A. Bloch, D. J. McShane, J. F. Fries, N. S. Cooper, L. A. Healey, S. R. Kaplan, M. H. Liang, H. S. Luthra, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315-324.
17. Bakheet, T., M. Frevel, B. R. Williams, W. Greer, and K. S. Khabar. 2001. ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res. 29: 246-254.
18. Page, G., A. Sattler, S. Kersten, A. Thiel, A. Radbruch, and P. Miossec. 2004. Plasma cell-like morphology of Th1-cytokine-producing cells associated with the loss of CD3 expression. Am. J. Pathol. 164: 409-417.
19. Ruddy, M. J., F. Shen, J. B. Smith, A. Sharma, and S. L. Gaffen. 2004. Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J. Leukocyte Biol. 76: 135-144.
20. Chabaud, M., G. Page, and P. Miossec. 2001. Enhancing effect of IL-1, IL-17, and TNF-α on macrophage inflammatory protein-3α production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. J. Immunol. 167: 6015-6020.
21. + CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood. J. Immunol. 180: 655-663.
22. Hirth, A., A. Skapenko, R. W. Kinne, F. Emmrich, H. Schulze-Koops, and U. Sack. 2002. Cytokine mRNA and protein expression in primary-culture and repeated-passage synovial fibroblasts from patients with rheumatoid arthritis. Arthritis Res. 4: 117-125.
23. Palmer, D. G., Y. Selvendran, C. Allen, P. A. Revell, and N. Hogg. 1985. Features of synovial membrane identified with monoclonal antibodies. Clin. Exp. Immunol. 59: 529-538.
24. Saalbach, A., R. Kraft, K. Herrmann, U. F. Haustein, and U. Anderegg. 1998. The monoclonal antibody AS02 recognizes a protein on human fibroblasts being highly homologous to Thy-1. Arch. Dermatol. Res. 290: 360-366.
25. Henderson, K. J., J. C. Edwards, and J. G. Worrall. 1994. Expression of CD44 in normal and rheumatoid synovium and cultured synovial fibroblasts. Ann. Rheum Dis. 53: 729-734.
26. Schwachula, A., D. Riemann, A. Kehlen, and J. Langner. 1994. Characterization of the immunophenotype and functional properties of fibroblast-like synoviocytes in comparison to skin fibroblasts and umbilical vein endothelial cells. Immunobiology 190: 67-92.
27. Hamann, J., J. O. Wishaupt, R. A. van Lier, T. J. Smeets, F. C. Breedveld, and P. P. Tak. 1999. Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue. Arthritis Rheum. 42: 650-658.
28. Scaife, S., R. Brown, S. Kellie, A. Filer, S. Martin, A. M. Thomas, P. F. Bradfield, N. Amft, M. Salmon, and C. D. Buckley. 2004. Detection of differentially expressed genes in synovial fibroblasts by restriction fragment differential display. Rheumatology 43: 1346-1352.
29. Seki, T., J. Selby, T. Haupl, and R. Winchester. 1998. Use of differential subtraction method to identify genes that characterize the phenotype of cultured rheumatoid arthritis synoviocytes. Arthritis Rheum. 41: 1356-1364.
30. Schwarting, A., J. Schlaak, J. Lotz, I. Pfers, K. H. Meyer zum Buschenfelde, and W. J. Mayet. 1996. Endothelin-1 modulates the expression of adhesion molecules on fibroblast-like synovial cells (FLS). Scand. J. Rheumatol. 25: 246-256.
31. Kasperkovitz, P. V., T. C. Timmer, T. J. Smeets, N. L. Verbeet, P. P. Tak, L. G. van Baarsen, B. Baltus, T. W. Huizinga, E. Pieterman, M. Fero, et al. 2005. Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: evidence of a link between an increased myofibroblast-like phenotype and high-inflammation synovitis. Arthritis Rheum. 52: 430-441.
32. Zhu, P., N. Lu, Z. G. Shi, J. Zhou, Z. B. Wu, Y. Yang, J. Ding, and Z. N. Chen. 2006. CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes. Arthritis Res. Ther. 8: R44.
33. Dulos, J., A. Kaptein, A. Kavelaars, C. Heijnen, and A. Boots. 2005. Tumour necrosis factor-α stimulates dehydroepiandrosterone metabolism in human fibroblast-like synoviocytes: a role for nuclear factor-κB and activator protein-1 in the regulation of expression of cytochrome p450 enzyme 7b. Arthritis Res. Ther. 7: R1271-R1280.
34. Dulos, J., M. A. van der Vleuten, A. Kavelaars, C. J. Heijnen, and A. M. Boots. 2005. CYP7B expression and activity in fibroblast-like synoviocytes from patients with rheumatoid arthritis: regulation by proinflammatory cytokines. Arthritis Rheum. 52: 770-778.
35. Chabaud, M., F. Fossiez, J. L. Taupin, and P. Miossec. 1998. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J. Immunol. 161: 409-414.
36. Dechanet, J., J. L. Taupin, P. Chomarat, M. C. Rissoan, J. F. Moreau, J. Banchereau, and P. Miossec. 1994. Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes. Eur. J. Immunol. 24: 3222-3228.
37. Kim, H. R., M. L. Cho, K. W. Kim, J. Y. Juhn, S. Y. Hwang, C. H. Yoon, S. H. Park, S. H. Lee, and H. Y. Kim. 2007. Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-κB- and p38 MAPK-dependent signalling pathways. Rheumatology 46: 57-64.
38. Marlor, C. W., D. L. Webb, M. P. Bombara, J. M. Greve, and M. L. Blue. 1992. Expression of vascular cell adhesion molecule-1 in fibroblastlike synoviocytes after stimulation with tumor necrosis factor. Am. J. Pathol. 140: 1055-1060.
39. Schnyder, B., S. Schnyder-Candrian, A. Pansky, M. L. Schmitz, M. Heim, B. Ryffel, and R. Moser. 2005. IL-17 reduces TNF-induced RANTES and VCAM-1 expression. Cytokine 31: 191-202.
40. Cagnard, N., F. Letourneur, A. Essabbani, V. Devauchelle, S. Mistou, A. Rapinat, C. Decraene, C. Fournier, and G. Chiocchia. 2005. Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes. Eur. Cytokine Network 16: 289-292.
41. Hartupee, J., C. Liu, M. Novotny, X. Li, and T. Hamilton. 2007. IL-17 enhances chemokine gene expression through mRNA stabilization. J. Immunol. 179: 4135-4141.
42. Wilusz, C. J., M. Wormington, and S. W. Peltz. 2001. The cap-to-tail guide to mRNA turnover. Nat. Rev. Mol. Cell Biol. 2: 237-246.
43. Toh, M. L., and P. Miossec. 2007. The role of T cells in rheumatoid arthritis: new subsets and new targets. Curr. Opin. Rheumatol. 19: 284-288.
44. Chabaud, M., J. M. Durand, N. Buchs, F. Fossiez, G. Page, L. Frappart, and P. Miossec. 1999. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 42: 963-970.
45. + T cells. J. Biol. Chem. 282: 13447-13455.
46. Kanbe, K., K. Takagishi, and Q. Chen. 2002. Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell-derived factor 1 and CXC chemokine receptor 4. Arthritis Rheum. 46: 130-137.
47. Nanki, T., K. Nagasaka, K. Hayashida, Y. Saita, and N. Miyasaka. 2001. Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis. J. Immunol. 167: 5381-5385.
48. Garcia-Vicuna, R., M. V. Gomez-Gaviro, M. J. Dominguez-Luis, M. K. Pec, I. Gonzalez-Alvaro, J. M. Alvaro-Gracia, and F. Diaz-Gonzalez. 2004. CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients. Arthritis Rheum. 50: 3866-3877.
49. Santiago, B., F. Baleux, G. Palao, I. Gutierrez-Canas, J. C. Ramirez, F. Arenzana-Seisdedos, and J. L. Pablos. CXCL12 is displayed by rheumatoid endothelial cells through its basic amino-terminal motif on heparan sulfate proteoglycans. Arthritis Res. Ther. 8: R43, 2006.
50. Grassi, F., A. Piacentini, S. Cristino, S. Toneguzzi, C. Cavallo, A. Facchini, and G. Lisignoli. 2003. Human osteoclasts express different CXC chemokines depending on cell culture substrate: molecular and immunocytochemical evidence of high levels of CXCL10 and CXCL12. Histochem. Cell Biol. 120: 391-400.
51. Kanbe, K., T. Takemura, K. Takeuchi, Q. Chen, K. Takagishi, and K. Inoue. 2004. Synovectomy reduces stromal-cell-derived factor-1 (SDF-1) which is involved in the destruction of cartilage in osteoarthritis and rheumatoid arthritis. J. Bone Joint Surg. Br. 86: 296-300.
52. Joosten, L. A., M. G. Netea, S. H. Kim, D. Y. Yoon, B. Oppers-Walgreen, T. R. Radstake, P. Barrera, F. A. van de Loo, C. A. Dinarello, and W. B. van den Berg. 2006. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 103: 3298-3303.
53. Shoda, H., K. Fujio, Y. Yamaguchi, A. Okamoto, T. Sawada, Y. Kochi, and K. Yamamoto. 2006. Interactions between IL-32 and tumor necrosis factor α contribute to the exacerbation of immune-inflammatory diseases. Arthritis Res. Ther. 8: R166.
54. Kim, S. H., S. Y. Han, T. Azam, D. Y. Yoon, and C. A. Dinarello. 2005. Interleukin-32: a cytokine and inducer of TNFα. Immunity 22: 131-142.
55. Clark, A. 2000. Post-transcriptional regulation of pro-inflammatory gene expression. Arthritis Res. 2: 172-174.
56. McAllister, F., A. Henry, J. L. Kreindler, P. J. Dubin, L. Ulrich, C. Steele, J. D. Finder, J. M. Pilewski, B. M. Carreno, S. J. Goldman, et al. 2005. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-α and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J. Immunol. 175: 404-412.
57. Kehlen, A., K. Thiele, D. Riemann, and J. Langner. 2002. Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis. Clin. Exp. Immunol. 127: 539-546.
58. Hwang, S. Y., J. Y. Kim, K. W. Kim, M. K. Park, Y. Moon, W. U. Kim, and H. Y. Kim. 2004. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-κB- and PI3-kinase/Akt-dependent pathways. Arthritis Res. Ther. 6: R120-R128.
59. Andoh, A., S. Fujino, S. Bamba, Y. Araki, T. Okuno, T. Bamba, and Y. Fujiyama. 2002. IL-17 selectively down-regulates TNF-α-induced RANTES gene expression in human colonic subepithelial myofibroblasts. J. Immunol. 169: 1683-1687.
60. Granet, C., W. Maslinski, and P. Miossec. 2004. Increased AP-1 and NF-κB activation and recruitment with the combination of the proinflammatory cytokines IL-1β, tumor necrosis factor α and IL-17 in rheumatoid synoviocytes. Arthritis Res. Ther. 6: R190-R198.
61. Ruddy, M. J., G. C. Wong, X. K. Liu, H. Yamamoto, S. Kasayama, K. L. Kirkwood, and S. L. Gaffen. 2004. Functional cooperation between interleukin-17 and tumor necrosis factor-α is mediated by CCAAT/enhancer-binding protein family members. J. Biol. Chem. 279: 2559-2567.